These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 15843806

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A novel adenoviral vector-mediated neuronal selective gene expression in neonatal mouse brain in response to hypoxia.
    Hou ST, Jiang SX, Huang D, Desbois A.
    Neurosci Lett; 2007 May 23; 419(1):23-7. PubMed ID: 17418946
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development of a hypoxia-responsive vector for tumor-specific gene therapy.
    Shibata T, Giaccia AJ, Brown JM.
    Gene Ther; 2000 Mar 23; 7(6):493-8. PubMed ID: 10757022
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tumor-specific adenoviral gene therapy: transcriptional repression of gene expression by utilizing p53-signal transduction pathways.
    Kühnel F, Zender L, Wirth T, Schulte B, Trautwein C, Manns M, Kubicka S.
    Cancer Gene Ther; 2004 Jan 23; 11(1):28-40. PubMed ID: 14681724
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area.
    Kügler S, Kilic E, Bähr M.
    Gene Ther; 2003 Feb 23; 10(4):337-47. PubMed ID: 12595892
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neuron-restrictive silencer elements mediate neuron specificity of adenoviral gene expression.
    Millecamps S, Kiefer H, Navarro V, Geoffroy MC, Robert JJ, Finiels F, Mallet J, Barkats M.
    Nat Biotechnol; 1999 Sep 23; 17(9):865-9. PubMed ID: 10471926
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect.
    Su H, Huang Y, Takagawa J, Barcena A, Arakawa-Hoyt J, Ye J, Grossman W, Kan YW.
    Gene Ther; 2006 Nov 23; 13(21):1495-502. PubMed ID: 16775632
    [Abstract] [Full Text] [Related]

  • 15. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ.
    Breast Cancer Res Treat; 2009 Sep 23; 117(1):45-54. PubMed ID: 18791823
    [Abstract] [Full Text] [Related]

  • 16. Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector.
    Laurie KL, Blundell MP, Baxendale HE, Howe SJ, Sinclair J, Qasim W, Brunsberg U, Thrasher AJ, Holmdahl R, Gustafsson K.
    Gene Ther; 2007 Dec 23; 14(23):1623-31. PubMed ID: 17851547
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Transcriptional targeting of acute hypoxia in the tumour stroma is a novel and viable strategy for cancer gene therapy.
    Ingram N, Porter CD.
    Gene Ther; 2005 Jul 23; 12(13):1058-69. PubMed ID: 15800661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.